FDA rejects Scholar Rock's apitegromab application due to facility issues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/31/2026

1. AMZN
2. RBLX
3. AAPL
4. COIN
5. RDDT
6. NBIX
7. DXCM
8. FND
9. GH
10. GDDY

Go back to FDA rejects Scholar Rock's apitegromab application due to facility issues
(NASDAQ: SRRK) Delayed: 47.30 -1.69 (3.45%)
Previous Close $48.99    52 Week High $ 
Open $49.04    52 Week Low $ 
Day High $49.33    P/E N/A 
Day Low $46.92    EPS $ 
Volume 786,740